Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03161223
Brief Title: Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

First Submitted : May 18, 2017
First Submitted that Met QC Criteria : May 18, 2017
First Posted : May 19, 2017

Last Update Submitted that Met QC Criteria : May 13, 2019
Last Update Posted : May 15, 2019